TipRanks
Go Ultimate55% OFF

Nortech Systems (NSYS) AI Stock Analysis

NSYS

Nortech Systems

(NASDAQ:NSYS)

Select Model
Rating:45Neutral
Price Target:$10.50â–²(0.96% Upside)
Action:reiterated
Date:08/17/26

NSYS scores 45, reflecting a company in early recovery with meaningful operational improvements offset by significant financial and technical headwinds. The strongest factor is the latest earnings call, which showed 9.3% revenue growth, record gross margins, a robust and growing backlog (+25.8% YoY on 90-day), and a YTD operating turnaround — suggesting improving fundamentals ahead. However, this is counterbalanced by weak historical financials marked by inconsistent profitability, volatile cash flows, and thin margins that leave little room for error. Technical indicators are firmly bearish with the stock trading below all key short- and medium-term moving averages and momentum indicators signaling continued weakness. Valuation at 32.9x P/E is stretched for a company with sub-1% net margins and no dividend. While the backlog growth and margin expansion trajectory are encouraging leading indicators, the stock needs to demonstrate sustained profitability improvement and technical stabilization before warranting a higher score.

Positive Factors
Backlog visibilityStrong growth in both near-term shipment backlog and total orders improves revenue visibility for upcoming quarters. The increase across aerospace and medical imaging programs gives Nortech a tangible demand base to convert into sales, although execution remains important.
Negative Factors
Thin profitabilityThe recovery has not yet produced substantial profitability relative to sales, leaving limited protection against labor, component, or operating-cost increases. Thin margins make earnings more sensitive to program mix and execution and could constrain internally funded growth.

Nortech Systems (NSYS) vs. SPDR S&P 500 ETF (SPY)

-50%-25%0%25%50%75%100%NSYS+7.44%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$29.68M
Dividend Yield
―
Average Volume (3M)
12.23K
Price to Earnings (P/E)
28.3
Beta (1Y)
0.36
Revenue Growth
6.00%
EPS Growth
―
Country
US
Employees
699
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

Nortech Systems Business Overview & Revenue Model

Company Description

Nortech Systems Incorporated, founded in 1990 and headquartered in Maple Grove, Minnesota, specializes in delivering comprehensive design and manufacturing solutions. The company provides end-to-end services for various intricate systems, including e...

How the Company Makes Money

Nortech Systems makes money primarily by manufacturing electronics and electromechanical products on behalf of original equipment manufacturers (OEMs) under contract. Its core revenue streams are (1) build-to-print manufacturing—producing PCB assembl...

Nortech Systems Earnings Call Summary

Earnings Call Date:Aug 11, 2026(Q2-2026)|% Change Since:-31.62%|Next Earnings Date:May 14, 2019
Earnings Call SentimentPositive

The call presented a largely constructive operational and financial picture: revenue grew 9.3% YoY, gross margin improved by 120 basis points, backlog increased significantly (90-day backlog +25.8% YoY; total backlog +19.8% YoY), and the company achieved a year-to-date operating turnaround from a loss to positive operating income. Offsetting these positives are meaningful near-term costs and risks — notably materially higher incentive and stock-based compensation that increased operating expenses, short-term declines in aerospace and industrial sales, working capital pressure (low cash balance and inventory build to support backlog), and uncertainty around tariff recoveries and supply chain constraints. Overall the improvements in revenue, margin, backlog and YTD profitability outweigh the listed challenges, suggesting constructive momentum with manageable near-term headwinds.

Positive Updates

Revenue Growth
Net sales increased 9.3% year-over-year to $33.5 million in Q2 2026 (up $2.9 million vs Q2 2025).

Negative Updates

Higher Operating Expenses Driven by Incentive Compensation
Total operating expenses rose to $5.1 million in Q2 2026 from $4.1 million a year ago; incentive compensation expense materially increased — $402,000 in Q2 and $647,000 YTD versus a $131,000 reversal in Q2 2025 — resulting in incentive-related expense being $533,000 and $647,000 higher than respective 2025 periods.

Company Guidance

Management did not give formal forward-looking numeric guidance but emphasized converting a stronger backlog, reducing inventory and working capital to generate cash, and driving further margin expansion and operating leverage; they cited Q2 net sales of $33.5M (+9.3% YoY), gross profit $5.7M and gross margin of 17% (up 120 bps), Q2 operating income $623k (YTD operating income $670k vs. prior-year operating loss $871k), and Q2 net income $316k ($0.11 diluted) with YTD net income $282k ($0.09) vs. a $1.0M loss ($0.36) a year earlier. Backlog remained a key leading indicator: 90‑day shipment backlog was $33.4M (+6.3% sequential, +25.8% YoY) and total order backlog was $93.8M (+3.4% sequential, +19.8% YoY). Market trends cited included medical device sales +36% YoY, medical imaging +12.2%, industrial -4.7%, and aerospace & defense -12.8% in Q2 (but +8.7% YTD); incentive compensation expense was $402k (Q2) and $647k (YTD), $533k and $647k higher than 2025 comparatives. Liquidity and working capital metrics: cash and restricted cash $1.7M, revolving credit balance $7.6M with $3.6M unused availability, cash used in operating activities $2.4M YTD (vs. $2.8M prior), cash used by AR/contract assets $4.5M, cash used by inventory $3.5M and cash provided by AP changes $2.1M; management also noted record first-half gross margin and ample capacity across 4 Minnesota sites plus Monterrey and Suzhou to grow without significant CapEx.

Nortech Systems Financial Statement Overview

Summary

Nortech Systems' financials reflect a company in early-stage recovery after a difficult 2024. Revenue declined from ~$139M to ~$118M before showing TTM stabilization at ~$125M. Profitability has been highly inconsistent with net losses in two of the last three annual periods and razor-thin TTM net margins of 0.8%. Gross margins in the mid-teens are modest for the industry. The balance sheet benefits from meaningful deleveraging (debt reduced from $20M+ to $10M), but ROE remains very low at 3%. Cash flow has been erratic with multiple years of negative operating and free cash flow, though the TTM period shows modest positive free cash flow of $1.9M. The income statement score of 35, balance sheet score of 52, and cash flow score of 40 collectively paint a picture of a fragile financial foundation with early signs of stabilization.

Income Statement

35Negative

Balance Sheet

52Neutral

Cash Flow

40Negative
Financial statement breakdown
BreakdownTTMDec 2025Mar 2025Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue124.65M118.36M128.13M139.33M134.12M115.17M
Gross Profit20.50M18.01M16.72M23.10M20.48M15.86M
EBITDA3.74M2.26M1.54M8.00M5.81M10.39M
Net Income1.03M-252.00K-1.29M6.87M2.01M7.15M
Balance Sheet
Total Assets80.05M71.92M72.44M75.13M69.54M67.09M
Cash, Cash Equivalents and Short-Term Investments1.38M1.66M916.00K960.00K1.03M643.00K
Total Debt17.89M15.71M18.04M14.18M16.51M20.21M
Total Liabilities44.57M37.37M38.43M39.78M41.46M40.98M
Stockholders Equity35.47M34.55M34.01M35.34M28.08M26.11M
Cash Flow
Free Cash Flow1.93M2.08M-3.52M485.00K2.96M-5.83M
Operating Cash Flow3.07M2.74M-2.25M1.77M5.40M-4.54M
Investing Cash Flow-122.00K-157.00K-1.26M-1.28M-2.43M-730.00K
Financing Cash Flow-1.95M-1.87M2.77M-1.28M-2.67M3.93M

Nortech Systems Technical Analysis

Technical Analysis SentimentNegative
Last Price10.40

Price Trends

50DMA11.20Negative
100DMA12.94Negative
200DMA12.29Negative

Market Momentum

MACD-0.21Negative
RSI43.33Neutral
STOCH52.17Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NSYS, the sentiment is Negative. The current price of 10.40 is below the 20-day moving average (MA) of 10.71, below the 50-day MA of 11.20, and below the 200-day MA of 12.29, indicating a bearish trend. The MACD of -0.21 indicates Negative momentum. The RSI at 43.33 is Neutral, neither overbought nor oversold. The STOCH value of 52.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NSYS.

Nortech Systems Risk Analysis

Nortech Systems disclosed 33 risk factors in its most recent earnings report. Nortech Systems reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Nortech Systems Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

NSYS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
LGLLGL67Neutral$85.14M-337.50-0.53%―26.35%-130.90%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
CPSHCPSH48Neutral$69.60M780.430.15%―25.56%―
MEIMEI48Neutral$524.70M-14.17-5.46%1.36%1.36%32.69%
DAIODAIO45Neutral$24.53M-2.54-68.36%―-21.81%-225.39%
NSYSNSYS45Neutral$29.68M28.282.99%―6.00%―
LINKLINK41Neutral$59.71M-48.59-10.92%―7.85%45.80%

* Healthcare Sector Average

Performance Comparison

0%100%200%NSYSDAIOLGLMEICPSHLINKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
NSYS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
NSYSNortech10.401.0310.99%
DAIOData I/o2.36-0.65-21.59%
LGLLGL Group6.750.548.70%
MEIMethode Electronics14.728.09121.99%
CPSHCPS Technologies Corp.3.590.102.87%
LINKInterlink Electronics, Inc.3.79-2.37-38.47%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 17, 2026